Recognition of the complexities of inositol lipid signaling has increased dramatically in the last several years. PtdIns(4,5)P2 directly binds and regulates activity of many proteins, and at least three major second messengers are produced in a single step from this minor membrane phospholipid. The inositol lipid-specific phospholipase C isozymes integrate signals from multiple upstream G protein regulators, and act as highly organized but poorly understood signaling nodes central to the action of many growth factors, hormones, neurotransmitters, and other stimuli. Recent work from our laboratories has led to increased appreciation of multiple modes of regulation of inositol lipid signaling by Rac, Rho, and heterotrimeric G proteins. Moreover, our structures of PLC-22 and of PLC-22 in GTP-dependent complex with Rac1 provide the first mechanistic snapshots of PLC isozymes past the original structure of PLC-4 solved a decade ago. This progress and recent success in producing stable complexes of G1q and PLC-2 isozymes has placed us in position to design experiments that will provide understanding of G protein-mediated regulation of the catalytic activity of PLC isozymes in structurally and mechanistically unambiguous terms. We propose three specific aims to reach this goal:
Specific Aim 1. To delineate the interface and mechanism through which GTP-bound Rho binds PLC-5 and cooperates with Ras in activation of this novel PLC isozyme.
Specific Aim 2. To define the structural basis of interaction of G1q with the carboxy-terminus of PLC-2 isozymes, and to delineate the mechanism through which this interaction stimulates PLC activity.
Specific Aim 3. To determine the mechanism whereby an auto-inhibiting occlusion of the active site by a catalytic domain insert is relieved during interfacial activation of PLC isozymes at phosphoinositide-containing membranes.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM057391-13
Application #
8053282
Study Section
Special Emphasis Panel (ZRG1-CB-G (01))
Program Officer
Dunsmore, Sarah
Project Start
1998-05-01
Project End
2012-04-30
Budget Start
2011-04-01
Budget End
2012-04-30
Support Year
13
Fiscal Year
2011
Total Cost
$385,053
Indirect Cost
Name
University of North Carolina Chapel Hill
Department
Pharmacology
Type
Schools of Medicine
DUNS #
608195277
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599
Huang, Weigang; Wang, Xiaoyang; Endo-Streeter, Stuart et al. (2018) A membrane-associated, fluorogenic reporter for mammalian phospholipase C isozymes. J Biol Chem 293:1728-1735
Charpentier, Thomas H; Waldo, Gary L; Lowery-Gionta, Emily G et al. (2016) Potent and Selective Peptide-based Inhibition of the G Protein G?q. J Biol Chem 291:25608-25616
Schrage, Ramona; Schmitz, Anna-Lena; Gaffal, Evelyn et al. (2015) The experimental power of FR900359 to study Gq-regulated biological processes. Nat Commun 6:10156
Charpentier, Thomas H; Waldo, Gary L; Barrett, Matthew O et al. (2014) Membrane-induced allosteric control of phospholipase C-? isozymes. J Biol Chem 289:29545-57
Schmitz, Anna-Lena; Schrage, Ramona; Gaffal, Evelyn et al. (2014) A cell-permeable inhibitor to trap G?q proteins in the empty pocket conformation. Chem Biol 21:890-902
Huang, Weigang; Barrett, Matthew; Hajicek, Nicole et al. (2013) Small molecule inhibitors of phospholipase C from a novel high-throughput screen. J Biol Chem 288:5840-8
Hajicek, Nicole; Charpentier, Thomas H; Rush, Jeremy R et al. (2013) Autoinhibition and phosphorylation-induced activation of phospholipase C-? isozymes. Biochemistry 52:4810-9
Gresset, Aurelie; Sondek, John; Harden, T Kendall (2012) The phospholipase C isozymes and their regulation. Subcell Biochem 58:61-94
Cherkis, Karen A; Temple, Brenda R S; Chung, Eui-Hwan et al. (2012) AvrRpm1 missense mutations weakly activate RPS2-mediated immune response in Arabidopsis thaliana. PLoS One 7:e42633
Wang, Xiaoyang; Barrett, Matthew; Sondek, John et al. (2012) Fluorescent phosphatidylinositol 4,5-bisphosphate derivatives with modified 6-hydroxy group as novel substrates for phospholipase C. Biochemistry 51:5300-6

Showing the most recent 10 out of 23 publications